62 min listen
035 - Empagliflozin and dulaglutide
FromHelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
035 - Empagliflozin and dulaglutide
FromHelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
ratings:
Length:
34 minutes
Released:
Nov 24, 2015
Format:
Podcast episode
Description
In this episode, we discuss two new anti-diabetic medications: empagliflozin (Jardiance) and the EMPA-REG OUTCOME trial as well as dulaglutide (Trulicity), a new GLP1 agonist.
Released:
Nov 24, 2015
Format:
Podcast episode
Titles in the series (100)
015 - Cancer Screenings: In this episode, we review a wide variety of cancer screening guidelines with a particular focus on the two most controversial screening areas: breast cancer screening with mammography and prostate cancer screening with PSA levels. by HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast